AimingMed
The startup develops precision oncology solutions using tumor organoids for drug screening and evaluation model construction. This technology enables medical enterprises to accelerate drug research and development while significantly reducing associated costs.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops precision oncology solutions using tumor organoids for drug screening and evaluation model construction. This technology enables medical enterprises to accelerate drug research and development while significantly reducing associated costs.